Cuong Do leads BioVie as its CEO. BioVie Inc is listed on the NASDAQ exchange and is seeking FDA review for its drug candidate.
11 reports, 4 independent
Updated Nov 2
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 11
- Developments
- 4
- Repetition
- 64%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cuong Do leads BioVie as its CEO. BioVie Inc is listed on the NASDAQ exchange and is seeking FDA review for its drug candidate.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BioVie scheduled to present data at a conference in Nice.1 source
BioVie held a clinical meeting in San Diego while listed on Nasdaq.1 source
Biovie submitted analyses to the FDA while listed on the Nasdaq exchange.1 source
BioVie announces CEO appointment, NASDAQ listing, and FDA review status for its drug candidate.1 source
Keep exploring
The entities involved
Related events
Coverage
Newest first; wire copies grouped- proactiveinvestors.com
- manilatimes.net
- tickerreport.com
- finanznachrichten.de
- finanznachrichten.de
- proactiveinvestors.com